- Earnings call transcript Q1 2023

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good afternoon, and welcome to the Accuray First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] after today’s presentation there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Ken Mobeck, Accuray, Vice President, Finance. ahead. go Please

Ken Mobeck

and call operator, quarter everyone. to XX, Welcome fiscal Thank review good financial conference XXXX. September ended to XXXX, first results Accuray’s year you, which afternoon, for of the

management afternoon, this call our will recent corporate review developments. During

Suzanne call Executive Ali Chief Joining Accuray’s President Officer. and Accuray’s are on and Winter, us Pervaiz, Financial today’s Chief Officer;

these cause except the forward-looking may we as these required Exchange items forward-looking or includes date, assume and to call for forward-looking and today reliance on afternoon, begin, our are that filings or just call contemplated Commission. on statements. housekeeping could update that I Before Factors those result on we market Actual statements few to statements. would forth results our differ to undue materially a this information Securities this of differ press today’s after based results you A the any set any are us of closed The implied from as like in in the by to issued well remind as release put information we securities events, materially with the by law. statements today’s you forward-looking not as extent future to no forward-looking should Accordingly, obligation applicable available call. new statements.

follow-ups. that themselves two to then limit with we participants during the Q&A any request Session, First, questions and re-queue

our a make year references all in prepared are to we quarter fiscal Second, the remarks quarters. specific to

ended quarter For example, XX, our September regarding XXXX. refer fiscal to quarter first our statements first

directly With call Executive let to can call, deck slide page me turn Winter. at be Chief be investors.accuray.com. Additionally, to that, a supplemental Investor there accessed Accuray’s Suzanne going by Accuray’s this Suzanne. which to Officer, over the accompany will

Suzanne Winter

to solutions to that you innovative and service next we our guidance long-term year growing and all outcomes on faster the such, challenging market cash a improve offering to care I by new will continue delivering revenue year for reiterating the introduced the our XXXX, the on shareholder will of team significant afternoon we our and operating growing thank EBITDA. environment of we the start joining out R&D, QX, Thank I’m stakeholders, pipeline first made growth plan improving and how of differentiated the fiscal fiscal In and years. Accuray of as at differentiated solid this reminder we macroeconomic several and In enhancing fiscal despite on strategy. we finally for than call. from share the of quarter, fiscal a delivered laid in the proud and Good quarter commitment focused have afternoon advancing business solutions robust deliver margins you, flow. Ken. with the over are progress a delivering and execute product value our and which investments in growth revenue, solutions, business end

as radiotherapy Show at already impact. to highest a represents result, radiation important cancer a therapy ASTRO Antonio, one tools treat that system. cancer. addition community This At C-RAD. patients technology. one Synchrony lifetime, launched in helical an COVID new we and to in to VitalHold, getting back cancer is show, surface an eight automated breast the Radixact the attendance nearly the on pre level volumes cancer the department. evaluating will guided ClearRT integrated, delivery of for to most development solution where provides breast wonderful recently comprehensive with are Radixact our San partnership and in of we Quality Ultra women in to High the their be see our VitalHold, we of typical While with breast because starting attended customers the oncology diagnosed in adaptive execution achievement was procedure see This the plan, Texas, with breast it with and the We and Imaging radiation are the early

Additionally, will five ARTemis represents that helical treatment Technology adaptive ARTemis occur partnership images proprietary or in during newest a that to in for delivery adapt in powerful at RaySearch’s treatments and Accuray between RaySearch, uses Synchrony in critical treatment Accuray’s a planning OIS to leader we systems. ARTemis, for innovation, competitive fractions. shorter regimen capability tool the less can patient’s treatment Radixact deliver treatment for powered treatment to dose CT delivery with changes and ASTRO, the appointments. demonstrated over online AI algorithms changes our ClearRT combination be with corrects a condition advantage of plan with the a the

globally. we placed us a precision have GE post Healthcare. new with chose our allow solutions planning innovation strategic brand to we the Earlier partnerships, with will both Lab, to we have advance key and companies solutions because its medical global oncology precision class in on and cancer personalized strategy, enabled of The as delivery, Brain C-RAT, high Accuray all centers global our to treatment. provide in announced of growth AI, throughout and solutions care month, such a precision monitoring to personalized priority industry GE agreement which a broadened Limbus markets, strong have pathway key commercial leadership diagnostics, this offer on Healthcare, leader care focus Precision a As treatment from execute partnership and best substantially RaySearch, Radiotherapy.

opinion treatment. opinion leaders registry will we technology significant companies leaders analysts where Key and commercial and breast of reimbursement. expand SBRT of key prostate both support for cancer Accuray reach for future At of between care, technology clinical session, clinical help investors Accuray discussed U.S. and joint the to time announced to leverage generates we of the is a Our footprint assist and radiotherapy. plans At demonstrating in technologies and ASTRO, for Two, cancer, in generation and detection reduce discuss One, clinical held session the the the practice. clinical that innovation evidence the neuro-functional driving and adoption expertise, best-in-class SRS global ways: to clinical three care. data advance goal finally with into cancer in impact and using

million For we increase for delivered and in shipments the few XX.X sub-components unable year-over-year. driven critical a in suppliers. in We sub planned delivery demand Japan revenue, quarter units the to were XX.X% Revenue to EIMEA. by delays quarter, to of from a strong due three reflected recognize

few we generally While supply continue suppliers. and support key improved, chain actively a conditions navigate to have

understand short, teams and our proactively are the conditions solutions until and mid However, long-term improve. issues addressing

the policy. to last demand is and is headwind, by regions. orders headwinds, macro are grew XX XX% the impact in driven seeing improving and growth system quarter evidenced CyberKnife the SX demand following adjusted customer Reported strong. approximately the due orders Additionally, primarily for the trends was down extraordinary orders. year-over-year, to flat as overall FX of underlying by revenue once APAC expected, This new was to XX% a zero X.X%, for China Americas year, approximately booked COVID their compared we We COVID. but Radixact due grew demand which pent-up Despite

region Type improved XX% encouraged driving came the China Synchrony revenue year-over-year, of Type with we Ultra rates signs pleased market. segment, see licenses, like first capturing A We by win our the ClearRT, to impact performance to trade-in, current the the Customers commercial are bidding The our their them year innovations quarters the China orders of bidding bunkers see grew we B holding delivered traction from XX were new over product we the wins the Despite and A the lifted segment. reactivation of encouraged processes, of a three second orders trade-up the of and have delay. China to installation after and In initiated that Type calendar to competitive successfully VOLO lockdown, in long Type continue including round COVID their to due planning within were are by system to our expect in A in on systems. XX% competitive which that of Systems, displacing XXXX. bidding see Accuray allowing be begin

Type to agency been advance the has month our one of process product I’m our NMPA and expectations JV in regulatory review. announce formally teams market Finally, is by for I’m our the and completed operations regulatory has pleased for progress testing pleased product all ahead have significant and with B that received been made submission to clearance.

Our spring the JV in partners calendar are of beginning launch initiating introductions XXXX. with targeted a full year market

beginning We service and our solutions of next to journey service continue over already on transformational improvements see service and announce in expect be support to make progress growth the This to a XXXX. second half in business and agenda. new margins for are several we years service will the our

and margin our have profitability expansion been Finally, activated. plan

identified for three pillars We focus. have our

capture innovation. to discipline our value First, for pricing higher

I’m execution this and operating our optimizing margin reducing product speak pleased our performance the and about profitability our will over discuss lastly, to quarter, of will and Overall, more it with of within teams our financial. cost, service to turn the Ali now Ali Second, expenses. I plan.

Ali Pervaiz

once product exchange unable chain representing was the from fiscal and was components, units $X million, and Suzanne, of good QX X% minute in XX% the million, $X.X adjusted FX, shortages, prior we revenue year challenges prior for fulfill Total once last the quarter impact. are to our Growth $XX.X by in critical $X.X quarter in first X.X% markets. the had to demand We which in and first down which year, I ongoing cross-functional for and by solid due impact fiscal million was FX. chain quarter was first like prior global $XX.X year COVID was million, up to million driven the would impact a ship the was shortages our down which from adjusted constant Ukraine, flat after lockdown able million the foreign for impact tough for prior non-U.S. approximately constraints up executed comparisons million who X.X% down FX XX% quarter a XX.X% a Product basis. quarter China, the despite on or the to afternoon, due but XX million, revenue headwind a last currency which compared revenue headwinds but Service quarter supply down early $XX.X to with dedication COVID October. $XX.X everyone. grew demand year customers once team war delays. thanking $X.X you, orders the revenue to in start for from were at to were to to global the including pressure, first of Thank deliver compared which when pent-up of inflationary to XXXX, three mainly for our FX in of planned was year, for adjusted supply XX.X%

the in our ratio, orders X.X gross compared at our earnings in level first discussed divided industry which as X.X prior was call, quarter, by healthy the defined X.X. book-to-bill to As standard revenue product a of is to which was

booking a excellent are convert teams to expected are progress revenue and efficient XX time We making more manner focus our prior orders months. to on to to that in continue

backlog. to Moving

reminder, order with As first driven lower other we million order year mainly customer with order adjustments. a and one of quarter, million We of younger. backlog that of prior canceled is beyond at aged million, is minimal backlog, backlogs only or FX the cancellations had $XX delays. is than which and report XX.X% which $X.X unit installation XX XX We million within this months due by $X.X $XXX ended product to months approximately

In in within are the that out previously. on orders of million the time this aged Our resulted converting quarter QX, global teams in to orders commercial revenue. revenue converting focused backlog $X.X had to all of regardless

Adjusted in was as unfavorable actions Our basis our year, shape discipline the in investment. prior EMEA. margins on overall the for lower growth points prior focused push that return million XX to the quarter adjusted and release EBITDA the $X.X on service cost due for we Operating quarter for $X.X GAAP than is in expenses quarter prior and The margin was the by impact, inflation revenue, to product the $X.X compared on business. cost to year. higher is expected pricing and between to million million issued primarily were $X.X in good $XX.X service with $XX.X was drive year, cost offset continue to XX.X% $X.X discipline an which for million FX are signals income net and compared are by compared control in of service today. particularly compared to a team mix, impact year. which be million had top Japan impact, the million FX Showing partially product in EBITDA line continued which our taking was decrease the improved driven minus and cost the quarter prior to million of Operating from described XX.X% income and earnings reconciliation

sheet, and $XX balance equivalent performance. from $XX.X as million at million cash, $XX receivable were amounted strong cash the Turning cash quarter million last to to we of compared end had down accounts last the total short-term million $XX restricted quarter. collections to Net

million, Our the inventory up we ongoing while our from million challenges service up net navigate was have ensuring $XX inventory year, built through healthy balance $XXX customer supply to fulfill our demand as to stock levels. chain prior

mentioned have plans areas. expansion focused margin that had we on our As three activated earlier, Suzanne are critical

value to is capture right the innovations. area discipline pricing our First for

profitability them right with to levels. value focus tools We on margin capturing incoming ensure arm orders on to have teams’ aligned incentive the and the and our commercial plans

organization, and in on installation. to and of our are offerings accommodate needs contracts Within the we pricing and areas service of up for customers, specifically adjusting enhanced renewal that service the training are working the

is second overall our area focus on The product to reducing costs.

Our our is with cost sourcing summit productivity with down partnership partner. key our organization JV focused high cost and suppliers parts, projects on engineering to on are teams working in drive

coming believe are on with in lowering projects the also We logistics the margins overall focus teams service outbound quarters. improve the our focused inbound and Additionally, will reduced costs. these costs

key direct and opportunity. Lastly, optimizing return all areas business, spend getting we our ensuring on in have indirect are are investments and of by the we we making identified expenses the are right relooking our the at operating and are

chain We XXXX that account levels. for facility note us our more for on taking to and we supply headwinds we these of exchange environment. position market remainder pre and will the into get taking are COVID as current of the It that amended is foreign track ourselves back important provide confident actions growth to to recently QX credit investment, FY flexibility the accelerated while and

QX. the had earlier, headwinds exchange factors chain supply were in As impacted and constraints business highlighted both biggest the foreign our Suzanne with two I have and that performance associated

can compared were X.X top-line chain impact impact environment, to our are our foreign year exchange markets. While and alone doing in supply we to million everything we rates where the non-US FX negative through manage to current last challenges the were exchange

are key in We the would highlights, and like and full-year FX. to macroeconomic closely the trends, with particularly will our back Those are monitor our I hand reiterating call guidance impact financial of that, Suzanne. to

Suzanne Winter

summary, provide would of teams highest customers Thank to like our I you, their patients. for to In Ali. the of thank unwavering our support so can care they level

expect growing about Accuray and and share. customer product adjusted of are Accuray continue and navigate the uncertainty expected $XX with revenue market We Technology million. in favor pipeline remain range the positioned $XX We Technology encouraged million remain of where conditions the of to optimistic to in demand win to the and million by and EBITDA trends our that we $XXX macroeconomic for take robust market geopolitical the guidance reiterate $XXX and range to million to and

we the fundamentals, catalysts we with China advancing our of growth our will in healthcare employees are back for meaningful over now value create our which partnership it new Q&A. strengthening like creating to I turn and and strategic As operator long-term an believe partnerships patients, Healthcare, for GE key providers, organization, will and shareholders. all

Operator

Street Lake Capital. Please Brooks question with Instructions] O’Neil from [Operator First ahead. comes go

Charlie Montang

This Montang Brooks is Charlie on O’Neil. Hi. for

with a quick integrate me. can is or do meaningful you hospital products to when questions from you GE and contribute the GE need Just you partnership to a think think more couple generate do revenue? do accounts revenue of to first one can My help

Suzanne Winter

Great. question. Thank for you the

have is And partnership, while the within strong think it for obviously muscle. do excited Together, with delivery. in we early we short-term deliver our very are solutions. precision the our very in we diagnostics a able to GE I better to They visibility have commercial precision will be from that the will think a solutions partnership. treatment We differentiated marketplace

government will they IDM and the level. leveraging access on the have of the market we have that more greater to by customer ability on team level, the So relationships the

key should strategic are as of to reference our just as well that indicators is short-term, funnel an the in in the So place think, as growth, looking ongoing see be we we we order to And developments I long-term financial. an increase performance key to going joint operating look should it then for for some solution And more start development. mechanisms. opportunity, opportunities a have for synergy and

Charlie Montang

a can and initial contribute my recently expect And submission with you. the then guys to great. the issued when approval expected is, release you of When to you you Okay, in Thank question Tomo orders China. say press revenue? is last

Suzanne Winter

for the you thank Yes, question.

We are JV China the starting it the we Type process to exciting. was developed this about that for things in B made our submission to are is waiting were product come move very that fact the and area enthusiastic that, so the complete China in is very in an regulatory and fact

Now predict probably typical it there is XX-months process, and a but regulatory course historically. can we never process of

what so regulatory to And XX-months be position. a able and be shipping clearance from is we orders would would be able to expecting we be have to take now, in

Charlie Montang

quarter. me on it you. That is Thank congrats Okay. a for great and

Suzanne Winter

Thank you.

Operator

with The Please next comes ahead. Cowen. from Jennings go question Josh

Josh Jennings

varying Siemens combination Thanks been ask, signal with reason side decided on integration of understand, with partner follow-up partnership. wanted of platforms big into a to other entity of question questions. Hi. for GE oncology just competitive I sense. on it secondarily, And the potential GE. taking better one Were the just to I partners radiation imaging the a you imaging Accuray oncology the systems. with guess, for and advanced competition that radiation multilayer I clearly Good to process that I evening. I the looking then GE wanted And for both the the, of leapfrog Accuray. for to both the the has a like validating risks seems guess, has the

into just integration ClearRT wanted from grade better everything that mean, be produce we know of little terms collaborations to taking it in Thanks for could of bit current, on imaging And thinking what I the what functional is term? is in imaging about is table. about MRI but understand so diagnostic talked and I should and full a the to platforms and longer R&D Accuray’s improving they this at to terms we incorporating to that that questions. the ASTRO, work

Suzanne Winter

question, for Thanks Josh. the

back to of is question. parts that think focused one GE From strategies I strategic the of of looking Healthcare on oncology peer and Just are kind have areas. two is of standpoint, they your they a area peel those are pathway that one of the to at

they Accuray, they They partner so to the the the And an of And chose in an with in time shorter I shorten see treatment. to for brand have millimeter see sub to duration to performance we terms high think between opportunity outstanding precision. diagnostics clinical also markets because our premium trend treatments.

we here fantastic. in together two which is be U.S. to so are Wisconsin, based happen And companies

have we so the for the a short-term commercial opportunity And collaboration. in

it at So delivery. building cancer looking presenting imaging are minimum customers one centers for comprehensive and company, face diagnostic - those both our like one is customers I a are a think that for treatment to solution that

with think think I more becoming for there key term, I is progresses exchange this much leader to certainly, which ever are time a to where great help do we important the planning. imaging how radiation imaging. as Imaging SIM therapy. think, of it we with such for GE products an from see sure is also treatment ClearRT I in is synergy. think is from diagnostic with products, and the will do they there are partnership reside. between an seeing opportunity that work completely treatment. and commercial opportunity to is why away Longer allows I to global that opinion That shorten us technology a Healthcare But is diagnostic it in don’t leaders uptick

Josh Jennings

again. Thanks

Operator

Please Chatterji ahead. comes question B. Neil from with go Your Riley. next

Neil Chatterji

the for getting thanks taking that registration question. JV guys, China Hi I congrats guess the submitted. on

with down Just China geo of having follow that. the the I help have of and view for regulatory geopolitical process risk kind from that and your does of and in any any potential And partner to or up. then domestic slow curious shield one terms see on just you kind

Suzanne Winter

are Thanks question, Obviously, closely. that very watching for the Neil. we

that and think of news have China And partially. I us a competitive think the gives We is JV hedge help what state-owned to of a midst in but we entity submission that based the regulatory good geopolitical the little will that, we is is advantage give that even that I our we advantage it is will part of in certainly a us process, watching think us bit partner an conditions, be in does opportunity whether it the happening. unclear. do

Neil Chatterji

Got aiding of of And about terms talked it, that of of just that strategy kind partnership is kind customer the - then, the kind helpful and relationships. the color. in the you

of kind that update and partnership for And we curious, expectations Just an launch for the XXXX of contouring. automated on remains AI integrated status of offering on the can still are then early if track an kind maybe whether for what get that. the Limbus

Suzanne Winter

thank Yes. question. No, the you Yep. for

I is being treatments. especially the happen of importance to in able the becoming think shorter important, ASTRO, duration coming changes these for even very out correct patient that with of

treatments fewer over it right they fewer more powerful to are appointments. got fractionation, because You get

a a strong also leader backed AI treatment in do with algorithm treatment have have partnership we so planning. is And planning. RaySearch. a for RaySearch very They

market to as quickly order And to best breed as decided bring so them we have to of in this with put possible. technologies together

we we to at approval, have do market demonstration but expecting the booth the development summertime ability a be not a and regulatory So difficult position. always expecting the RaySearch we ASTRO. and again, launch we shipment XXXX full judge, a so in to and and we show hopefully are And in to of this continuing are did are our booth, both in have of the

Neil Chatterji

Limbus sorry, specifically of on AI. kind And I asking was

Suzanne Winter

Yes.

So Limbus AI have. another is partnership that we

precision online our with own doing also adaptive planning RaySearch, for an capability we what So treatment on are outside the of are systems. we on looking

follow what introduce will we RaySearch. with that So

If do option. Accuray’s preference we what planning, our have as their as If are adaptive their an with they stay go Treatment with is RaySearch, to possible. trying options an to have to platform. is customers Precision they many will then is also give So online preference

is introduction. lag. would I RaySearch probably So from the I to say months that going And would from to anywhere say three just six

Neil Chatterji

you. Great. Thank

Operator

from The BTIG. with comes ahead. Thibault next Please go Marie question

Sam Eiber

Hey good afternoon ongoing these Eiber questions. and ones Thanks is of a differentiator Suzanne had moment. here I at could Is Ali. the same This have significant some those Marie. the just of these out? be taking trade-in Maybe on that of Sam in and the guess for driving how on that initially partnerships trade and competitive could impact following-up some multiple something Synchrony wins from when or ups? faster it ClearRT rolled

Suzanne Winter

for VitalHold, we Thank I example, which a which breast now introduced have that with you for question. we is that cancer think the that package. is the partnership C-RAD, us providing ASTRO Yes,

been Now, Radixact. our something very the systems. I would it asking and say trade that been on important have up for, and has that new And customers that is trade driving especially to

it improve System XX% of the And typical does because cancer are even breast radiation to department. the XX% Radixact about so versatility therapy a patients what is more now of

So true for to door have to and this and complex. it in that so now the ClearRT have is high the creating solution through workhorse addition very of being Synchrony very a come able cases patients really simple patients that solution to is a percentage

So we by are very encouraged that.

to systems a are of looking deliver the we versatility our increase our it with for and also add our value ability think partnership, differentiated I access proposition. to customers, have one of every

Sam Eiber

there, Suzanne. Got Maybe I one it. environment. order in more just Really can ask helpful the

a or a in strength the areas Another any relative gross strong I quarter from order maybe geography how standpoint standpoint. works weakness guess on here? of quarter here that

Suzanne Winter

say strength in construction. very seeing, and nice the are seeing would customers region, the a dynamics. would U.S. see. by really timeline. there to sort that stopped specifically of I would some a of were I to during revenue were mean, again, I as China it is the the supply was we their we were costs quarter, watching we this some the as Yes. standpoint, think means. of was a which say from own the that But saw market I installation orders out that coming impact it in the U.S. demand by little any they in I bit challenges see of only they started well not say to quarter, higher the on that see of region-by-region like thing of it very if seems were slowing U.S. strong. some some is the because is of installations And the delayed demand installation The primarily that chain APAC

to are that is if we something we going to temporary as that forward So continue a to watch solution. is move see, it

strong very say the alive the that happen. some were and said, is late again I will it on it a much to statement it Now, model. RO-APM, there going is the news in And new very which like reimbursement is that, breaking U.S. that looks CMS is making

may So some I that the impact do that have market. in think U.S.

out. we to how excited that that, but to see I’m will So see plays wait

Sam Eiber

taking the questions. Thanks for Great.

Operator

Loop Your Capital. next question Please comes from Jason with go Wittes ahead.

Jason Wittes

taking questions. for the thanks Hi,

China. First you how of what your sense Can revenue? and actually when rates in us a in of kind up hear be is give it encouraging to is the is the China those much and picked outlook recognizes order of in off, might terms backlog placed

Suzanne Winter

Yes.

is information has So in public specific say just script did been what process. through the numbers, the is, getting we bidding who but without in successful giving

strong to get the that this that because trajectory. through get have But so the should licenses times hot ability get to XX once A that don’t in approval to specific be And is quarters. is revenue off the bidding at press. sort point, it successfully are of their of several customers next that able Type they revenue terms sign holding systems We our were know a clarity of very We there that over process. we recognize that

Jason Wittes

in helpful. Am is might imagine something variance necessarily I You like are That are strict efficiencies more some secondly, service or that of focused on think, you sounds are I is you just I more internally put of that some is and then discounting, not internally is going it also that but that And sounds correctly? you comments. it margins, the - in are reading you there mentioned, focused meaning pricing? said Okay. And terms meaning you I to also for sales, tightening. to be putting that OpEx things, like think that protocols one, you be related greater focus consolidation to also on. Would in going Two

Suzanne Winter

Yes.

let bit little of a is it will both, Ali and I So comment.

Ali Pervaiz

Yes. No, thanks for the question.

will the that good you OpEx with continuing I a we pretty OpEx. is teams. one actually piece, drive So And finish number we discipline a of lot had see are because our on cost think to it on

know just you we making assessment that we make to of sure in are in both are all our macroeconomic direct so to a environment, make we are indirect scrubbing and has sure volatile costs the want that As return. right we anything and pretty that

OpEx So margin And little is then that on of side, the both bit is on side. Jason. a it the service it

are top making our offerings right getting pricing. that the sure on think, the we I are line,

quite importantly of margin us of from are But cost. intending new we on which on a standpoint. couple side, We also then think a more offerings, introducing there the is service a help bit will

engineer cost, and a are specifically we with making we look consumption our comes it also fuel sure to efficient are So that utilization. at of taking all being that parts just when then

Jason Wittes

the quick focused up but R&D the relationship. have wasn’t release, GE as collaboration just helpful maybe might in on before on is follow sure, been stated then is I That great. this distribution. also strictly And or is guess it well. Okay, there I a

Suzanne Winter

the in distribution. commercial short-term At is on agreement, this primarily point the focused is it that

Jason Wittes

Got lot. it. Thanks a

Operator

conference to our session. the like closing Winter over turn I to for back any remarks. question-and-answer would Suzanne concludes This

Suzanne Winter

thank earnings our on concludes your in attendance I we you call. and all want This to everyone the look earnings to speaking release. XXXX fiscal forward January for with Xst quarter second call again

Operator

The for you conference has presentation. today’s now Thank concluded. attending

now You may disconnect.

Accuray (ARAY) 3 Nov 222023 Q1 Earnings call transcript